Compared to EGFR+ or EGFR−/ALK− tumors, ALK+ tumors are more strongly associated with the absence of pulmonary metastasis and the presence of lymphangitic carcinomatosis, distant lymph node metastasis, and sclerotic bone metastasis[21]. The gene discussed is EGFR; the disease is metastasis.